Hedge fund manager Mitchell J. Blutt of the $1.5 billion Consonance Capital fund has made some intriguing portfolio shifts in the last quarter, including boosting his position in biopharma firm Catalyst Pharmaceuticals (NASDAQ:CPRX) and initiating stakes in drug makers Verastem (NASDAQ:VSTM) and Sesen Bio (NYSE:SESN). Dr. Blutt is one of the first physicians to play a major role […]

Whatever their motivations, spin-offs can have a dramatic effect on the performance of the associated corporate bonds, so it is crucial that fixed-income investors conduct the necessary analysis. Nathan N.J. Grant, CFA, has some advice.

The White House has told a number of US media outlets that Washington does not mind if Poland supplies Ukraine with some of its old Soviet-era warplanes to help repel the ongoing Russian invasion. “We are also working on the capabilities we could provide to backfill Poland if it decided to transfer planes to Ukraine,” the…